Aerie Pharmaceuticals Announces Positive Results For Phase 3 Rhopressa Trial
September 16, 2015 at 20:09 PM EDT
Shares of Aerie Pharmaceuticals are up 75% in after hours trade after the company announced positive phase 3 results for its Rhopressa eyedrops trial.